| mRNA |
Cytarabine |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
3e-18 |
| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
4e-13 |
| mRNA |
GSK461364 |
CTRPv2 |
pan-cancer |
AAC |
0.26 |
5e-12 |
| mRNA |
NPK76-II-72-1 |
GDSC1000 |
pan-cancer |
AAC |
0.23 |
8e-11 |
| mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-10 |
| mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
5e-10 |
| mRNA |
Mitomycin-C |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
1e-09 |
| mRNA |
Vorinostat |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
4e-09 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.22 |
4e-09 |
| mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
6e-09 |